Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goldstein

Showing results (341-350 of 569) with videos related to

Pageof 57
Sort By:
Antimicrobial Agents and Chemotherapy|December 12, 2007
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot woundsEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
The Clinical Neuropsychologist|January 10, 2025
ABBA Letter Alternation: A telehealth inspired measure of executive functioning/inhibitory controlDavid W Loring, Kelsey C Hewitt, Daniel L Drane, et al.
Diabetes/Metabolism Research and Reviews|November 25, 2014
Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experienceBenjamin A Lipsky, Chad M Cannon, Ananthakrishnan Ramani, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolatesEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalisEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2002
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bitesEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitisEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Human Mutation|February 15, 2019
MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new casesRebecca D Ganetzky, Claudia Stendel, Elizabeth M McCormick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancerRobert Ivkov, Sally J DeNardo, Wolfgang Daum, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 28, 2004
Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipientB Castiglioni, A Gautam, D M Citron, et al.
Pageof 57

Showing results (341-350 of 569) with videos related to

Sort By:
Pageof 57
Antimicrobial Agents and Chemotherapy|December 12, 2007
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot woundsEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
The Clinical Neuropsychologist|January 10, 2025
ABBA Letter Alternation: A telehealth inspired measure of executive functioning/inhibitory controlDavid W Loring, Kelsey C Hewitt, Daniel L Drane, et al.
Diabetes/Metabolism Research and Reviews|November 25, 2014
Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experienceBenjamin A Lipsky, Chad M Cannon, Ananthakrishnan Ramani, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolatesEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalisEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2002
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bitesEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitisEllie J C Goldstein, Diane M Citron, C Vreni Merriam, et al.
Human Mutation|February 15, 2019
MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new casesRebecca D Ganetzky, Claudia Stendel, Elizabeth M McCormick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancerRobert Ivkov, Sally J DeNardo, Wolfgang Daum, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 28, 2004
Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipientB Castiglioni, A Gautam, D M Citron, et al.
Pageof 57